At a glance
ClinicalIndex Comparison RecordN/ACompleted· 107 enrolled
Drug / intervention
Paracetamol 1000 mg +1 moredrug
Likely dose
Paracetamol 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non - Opioid Treatments (Single Administration) for Pain During the Early Postpartum Period After Vaginal Delivery
In Brief
A clinical study evaluating Paracetamol 1000 mg and Ibuprofen 400 mg for Pain. Completed, enrolled 107 participants across 1 site.
Detailed Summary
The investigators will examine the effectiveness of non-opioid analgesia (Paracetamol versus Ibuprofen) in the early postpartum period
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesIsrael
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartNov 2020
First PostedDec 2020
Primary CompletionJul 2022
Study CompletionJul 2023
TodayJul 2026
First PostedDec 4, 2020
Enrollment StartNov 28, 2020
Primary CompletionJul 1, 2022
Study CompletionJul 6, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.6 years ago
Interventions
Paracetamol 1000 mgdrug
Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg
Ibuprofen 400 mgdrug
Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg